ENDONOVO THERAPEUTICS, INC. Repayments of Convertible Debt
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Repayments of Convertible Debt of $40.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2023-12-29
- ENDONOVO THERAPEUTICS, INC. repayments of convertible debt for the quarter ending 2023-09-30 was $20.00K.
- ENDONOVO THERAPEUTICS, INC. repayments of convertible debt for the quarter ending 2023-06-30 was $0.00.
- ENDONOVO THERAPEUTICS, INC. repayments of convertible debt for the quarter ending 2023-03-31 was $20.00K.
- ENDONOVO THERAPEUTICS, INC. repayments of convertible debt for the quarter ending 2021-09-30 was -$5.00K.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month |
|---|---|---|---|
| 2023-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-29 | $20.00K derived: sum of 2 quarters · filed 2023-12-29 | $40.00K 10-Q · filed 2023-12-29 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $20.00K 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $20.00K 10-Q · filed 2023-05-22 | ||
| 2021-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | -$5.00K derived: sum of 2 quarters · filed 2022-11-21 | $3.00K 10-Q · filed 2022-11-21 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $8.00K 10-Q · filed 2022-08-22 | |
| 2021-03-31 | $8.00K 10-Q · filed 2022-05-19 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-19 | -$10.00K derived: sum of 2 quarters · filed 2020-11-19 | $130.00K 10-Q · filed 2020-11-19 |
| 2019-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-19 | $130.00K 10-Q · filed 2020-08-19 | |
| 2019-03-31 | $140.00K 10-Q · filed 2020-06-12 |